OZON Pharmaceuticals To Open New Manufacturing Hub In Dubai Industrial City

OZON Pharmaceuticals has entered into a "musataha agreement" to build a 150,700 sq.ft. manufacturing facility at Dubai Industrial City, a key industrial and logistics hub in the region. This new facility, part of TECOM Group PJSC, represents an investment exceeding AED293 million over two phases and is expected to be fully operational by next year.

The first phase of the project involves an AED110 million investment, aiming to produce over 300 million tablets annually. Upon completion, the facility will cater to significant markets within the GCC and regional countries such as Iraq, Morocco, Algeria, and Libya. The initial phase will employ 100 specialists in quality assurance, pharmaceutical control, and manufacturing.

The agreement was signed during an official ceremony attended by Dr. Thani bin Ahmed Al Zeyoudi, Minister of State for Foreign Trade; Omar Al Suwaidi, Undersecretary of the Ministry of Industry and Advanced Technology; and Alexey Gruzdev, Deputy Minister of Industry and Trade of the Russian Federation. The event took place on the sidelines of INNOPROM 2024 in Ekaterinburg.

Saud Abu Alshawareb, Executive Vice President of Industrial at TECOM Group, signed the agreement with Dr Mustafa Khalaf, General Manager at OZON Pharmaceuticals. Abu Alshawareb highlighted that localised medical manufacturing enhances supply chains, response times, and self-sufficiency. He noted these factors are crucial for embedding resilience in the healthcare sector.

Dr Khalaf expressed that their vision through this facility is to positively impact the manufacturing and healthcare sectors in the UAE, Middle East, and CIS regions by ensuring a steady supply of high-quality medicines. He added that they also aim to foster technological innovation and elevate healthcare standards in these areas.

Operational Goals

The new facility will feature advanced medicine tracking systems to ensure traceability and security throughout all stages of product development. This initiative aligns with Operation 300bn, Make it in the Emirates, and Dubai Economic Agenda ‘D33’ strategies aimed at achieving socioeconomic security through manufacturing.

OZON Pharmaceuticals joins over 1,000 local, regional, and international customers at Dubai Industrial City. This includes notable names like Standard Carpets, Himalaya Wellness, IFFCO Group, and Unilever among more than 300 operational factories.

This development marks another step towards strengthening the UAE's position as a leader in medical manufacturing within the region.

With inputs from WAM